Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis

Clinical Rheumatology

Volumn 33, Issue 2, 2014, Pages 277-280

  Alibaz Oner, Fatma ^a   Karatay, Emrah ^a   Akpinar, Ihsan Nuri ^a   Ergun, Tulin ^a   Direskeneli, Haner ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Asymptomatic; Beh et's disease; Venous insufficiency

Indexed keywords

ADULT; BEHCET SYNDROME; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MALE; MIDDLE AGED; PREVALENCE; SPONDYLITIS, ANKYLOSING; ULTRASONOGRAPHY, DOPPLER; VASCULAR DISEASES; VENOUS THROMBOSIS;

EID: 84893922670     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2382-4     Document Type: Article

References (17)

1. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet's disease. N Engl 341:1284-1291
2. Direskeneli H (2001) Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60(11):996-1002, Review. No abstract available
3. Mumcu G, Inanc N, Yavuz S, Direskeneli H (2007) The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease. Clin Exp Rheumatol 25(4 Suppl 45):S27-S33
4. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60-76
5. Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M et al (2010) Mortality in Behcet's disease. Arthritis Rheum 62:2806-2812
6. Kisacik B, Oren C, Kasifoglu T, Yilmaz S, Yilmaz O, Simsek I et al (2012) Investigation of the veins in patients with Behçet's disease with no known vascular event by Doppler ultrasonography. Rheumatol Int 32(2):303-306. doi: 10.1007/s00296-010-1603-2
7. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
8. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368
9. Nicolaides AN MS, FRCS, FRCSE (2000) Investigation of chronic venous insufficiency. Consensus Statement Circ 102:e126-e163
10. Labropoulos N, Tiongson J, Pryor L et al (2003) Definition of venous reflux in lower-extremity veins. J Vasc Surg 38:793-798
11. Aksu K, Donmez A, Keser G (2012) Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des 18(11):1478-93, Review
12. Pay S, Simsek I, Erdem H, Dinç A (2007) Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 27:417-424
13. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Expert Committee EULAR et al (2008) EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 67(12):1656-1662. doi: 10.1136/ard.2007. 080432
14. Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58(5):1539-1545. doi: 10.1002/art.23450
15. Hughes T, Coit P, Adler A, Yilmaz V, Aksu K, Düzgün N et al (2013) Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet. doi: 10.1038/ng.2551
16. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 42(8):698-702. doi: 10.1038/ng.625
17. Kuzu A, Köksoy C, Ozaslan C, Gürler A, Tüzüner A (1996) Evaluation of peripheral vascular system disorders in vascular symptom-free Behçet's disease. Cardiovasc Surg 4(3):381-383